Centene Corp.· CNC

🇺🇸 US · LargeSP500NYSE

Healthcare Medical - Healthcare Plans Website

Price: $64.58
Day: -3.67%
Mkt Cap: $31.90B
52W Range: $28.84 – $69.36
Volume: 4.32M
Beta: 1.11

5D Framework

Company Overview

Snapshot of fundamentals, performance, and 5D scores.

5D scores: Quality 2.4, Peers 2.5, Valuation 5.0, Analysts 3.8, Holdings 3.5 (out of 5)
Market: $64.58 a share, market cap $31.90B, +123.9% over 12 months
Company: Healthcare · Medical - Healthcare Plans, 61,100 employees, NYSE

Blog

Company Profile

Business fundamentals and company information

Business Description

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Key Details

CEO

Sarah McGinty London

Employees

61,100

Headquarters

St. Louis, MO, US

IPO Date

Dec 2001

Exchange

New York Stock Exchange

Phone

314 725 4477

Healthcare · Medical - Healthcare Plans

SEC filings

10-KFeb 17, 2026 10-QJul 28, 2026 8-KAug 17, 2026

Price Performance

Recent price action and historical returns

Price Performance

$64.58

Historical Returns

Price performance over time

1 Day

-3.67%

5 Day

+0.37%

1 Month

-1.81%

3 Months

-2.46%

6 Months

+77.42%

YTD

+56.94%

1 Year

+123.93%

3 Years

-1.27%

5 Years

+2.75%

10 Years

+89.83%

Revenue Analysis

How the business makes money, by product and geography

2025 revenue · 3 products

Revenue to Profit Flow · 2025

How revenue flows through the P&L: Products → Total Revenue → COGS → Gross Profit → operating costs (R&D, SG&A). Operating costs ran past gross profit this year, so the shortfall enters as its own band and the rest of the P&L is listed under the chart.

Learn how to read flow diagrams

Below the line. Nothing flows through an operating loss, so these are shown as figures rather than as flows.

Operating Loss-$7.62B
Other income$1.57B
Interest-$678.00M
Tax$50.96M
Net Loss-$6.67B

5D Framework

Five lenses on the stock. Click any card to dive deeper.

Quality

Business fundamentals

2.4/5

Weak

View Details

Peers

Competitive position

2.5/5

Weak

View Details

Valuation

Model-based valuation (vs. price)

5.0/5

Well below estimate

View Details

Analysts

Wall Street sentiment

3.8/5

Bullish

View Details

Holdings

Smart money flows

3.5/5

Bullish

View Details

How to read these dimensions

The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.